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Abstract
Malaria is caused by Plasmodium parasites, which invade and replicate in erythrocytes. For
Plasmodium falciparum, the major cause of severe malaria in humans, a heterotrimeric com-
plex comprised of the secreted parasite proteins, PfCyRPA, PfRIPR and PfRH5 is essential
for erythrocyte invasion, mediated by the interaction between PfRH5 and erythrocyte recep-
tor basigin (BSG). However, whilst CyRPA and RIPR are present in most Plasmodium spe-
cies, RH5 is found only in the small Laverania subgenus. Existence of a complex analogous
to PfRH5-PfCyRPA-PfRIPR targeting BSG, and involvement of CyRPA and RIPR in inva-
sion, however, has not been addressed in non-Laverania parasites. Here, we establish that
unlike P. falciparum, P. knowlesi and P. vivax do not universally require BSG as a host cell
invasion receptor. Although we show that both PkCyRPA and PkRIPR are essential for suc-
cessful invasion of erythrocytes by P. knowlesi parasites in vitro, neither protein forms a com-
plex with each other or with an RH5-like molecule. Instead, PkRIPR is part of a different
trimeric protein complex whereas PkCyRPA appears to function without other parasite bind-
ing partners. It therefore appears that in the absence of RH5, outside of the Laverania subge-
nus, RIPR and CyRPA have different, independent functions crucial for parasite survival.
Author summary
Malaria is one of the most devastating infectious diseases, causing significant human suf-
fering and death. It is caused by parasites of the genus Plasmodium proliferating in the
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bloodstream. Understanding the mechanism of erythrocyte invasion is key for developing
novel intervention strategies. P. falciparum, the cause of the most severe form of malaria,
requires the interaction of a trimeric protein complex RH5-CyRPA-RIPR with the host
receptor BSG for successful invasion. We show here that the BSG receptor is not essential
for invasion by two other major causes of human malaria, P. vivax and P. knowlesi. Fur-
thermore, we analyzed the role of CyRPA and RIPR in the absence of an RH5-like mole-
cule in P. knowlesi and show that these molecules do not associate to form a protein
complex unlike in the presence of RH5 in P. falciparum. PkRIPR is part of a different pro-
tein complex. Despite this difference CyRPA and RIPR still have essential functions dur-
ing host cell invasion in other important human malaria-causing parasites.
Introduction
Malaria, caused by Plasmodium parasites, remains a major world health problem with 219 mil-
lion annual malaria cases and 435,000 deaths reported in 2017 [1]. While P. falciparum is
responsible for most deaths, predominantly in sub-Saharan Africa, P. vivax is responsible for
34% of all cases outside of Africa and is the dominant cause of malaria in the Americas [2].
P. knowlesi is primarily a macaque parasite, but zoonotic infection can cause death and severe
disease in humans, with a significant number of cases in Southeast Asia [3].
As part of their complex life cycle, Plasmodium parasites infect and replicate within erythro-
cytes to cause the clinical symptoms of malaria. This multi-step invasion process by Plasmo-
dium merozoites is crucial for survival and transmission of the parasite. Significant advances
have been made in dissecting this process, which typically takes less than 1 min [4]. This pro-
cess involves the merozoite surface, apical microneme and rhoptry organelle secretion, and an
actin-myosin parasite motor. Initial weak surface interactions between the merozoite and
erythrocyte [5] precede strong deformations of the erythrocyte caused by erythrocyte binding-
like (EBL) and reticulocyte binding-like (RBL) ligands released from apical organelles (the
micronemes and rhoptry neck, respectively) onto the merozoite surface, binding to their spe-
cific host cell receptors. These interactions appear to mediate the merozoite reorientation,
which is followed by the release of the rhoptries and moving junction formation between the
parasite and the erythrocyte. As the merozoite invades, the junction likely acts as the bridge
between the actin-myosin parasite motor and the host cell [6]. The invasion process is com-
pleted with the sealing of the parasitophorous vacuole (PV) and erythrocyte plasma
membrane.
Plasmodium has evolved an extended repertoire of EBL and RBL proteins that allow for
molecular redundancy in host cell recognition and invasion, likely a strategy to circumvent
erythrocyte receptor polymorphisms and host immune responses (reviewed in [7]). Non-
redundant exceptions are P. falciparum reticulocyte-binding protein homologue (RH) 5 [6], P.
vivax Duffy binding protein (DBP) [8], and P. knowlesi DBPα, all of which are considered
essential for human erythrocyte invasion [9,10].
PfRH5 is a highly conserved protein [11] that binds to BSG on the erythrocyte. Antibodies
targeting either PfRH5 or BSG potently block invasion, as does the lack of BSG on an erythro-
leukemic BSG knockout cell line [12–16]. Its essentiality, its high degree of sequence conserva-
tion and its susceptibility to antibody targeting render PfRH5 a promising vaccine candidate,
which has been confirmed experimentally using PfRH5-based formulations to protect Aotus
monkeys against a virulent, heterologous P. falciparum challenge [17].
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PfRH5 is localized to the rhoptries [6,18] and, upon secretion, forms a heterotrimeric com-
plex with two micronemal proteins, cysteine rich protective antigen (PfCyRPA) and RH5-in-
teracting protein (PfRIPR) [19,20]. This complex follows the moving junction during invasion
[6,21]. Both PfCyRPA and PfRIPR are essential for invasion, and antibodies against either
have shown invasion-blocking potential [19–21]. None of the trimeric complex components
has a membrane anchor, but recently the GPI-anchored protein P113 has been proposed to
anchor the complex to the merozoite surface [22].
Inhibiting the PfRH5-BSG interaction, or using inducible PfRIPR and PfCyRPA knockout
parasites, indicates the complex functions during invasion following the strong deformations
caused by EBL and RBL protein binding, and prior to moving junction formation [4,12,21].
The use of erythrocytes loaded with a Ca2+ reporter suggests that the PfRH5-BSG interaction
may establish a physical connection between the cells, enabling Ca2+ diffusion from the mero-
zoite into the erythrocyte [4,12,21,23]. Although the Ca2+ signal was only detected in ~50% of
invasion events, a role was proposed for PfRH5-BSG in triggering rhoptry release, an essential
step of invasion. Recently, multimeric RIPR-RH5 structures that form on and integrate into
the erythrocyte membrane during invasion, were proposed [24]. It was hypothesized that these
form pores, although no evidence for Ca2+ diffusion through these structures was provided.
Despite this apparent key role of RH5 in P. falciparum erythrocyte invasion, no orthologue
of Pfrh5 has been identified in the genomes of any other Plasmodium species beyond those
closely related to P. falciparum, in the Laverania subgenus [11,25,26]. In contrast, orthologues
of Pfripr and Pfcyrpa are found in all or most Plasmodium species, respectively. Therefore, rea-
soning that the PfRH5-RIPR-CyRPA complex must mediate a universally essential step during
host cell invasion, we sought to determine whether PkRIPR and PkCyRPA are required for P.
knowlesi growth in the absence of a PfRH5 orthologue, and whether these proteins are part of
a protein complex involved in erythrocyte invasion by P. knowlesi. We further investigate what
role BSG plays during erythrocyte invasion of two important human malaria-causing parasites,
P. knowlesi and P. vivax. We show that unlike P. falciparum neither P. vivax nor P. knowlesi
are wholly dependent on erythrocyte BSG for successful invasion. Using CRISPR/Cas9 gene
editing paired with DiCre recombinase methodology to generated inducible gene deletions,
we demonstrate here that both Pkcyrpa and Pkripr are essential for P. knowlesi survival in vitro
and are involved in the erythrocyte invasion process. However, these proteins do not form a
complex with each other; instead, PkRIPR is part of a different trimeric protein complex,
whilst no binding partners were identified for PkCyRPA. We conclude that the essentiality of
the PfRH5-RIPR-CyRPA complex binding to erythrocyte BSG is unique to P. falciparum and
the Laverania, with divergent ligand-receptor complexes likely fulfilling this key mechanistic
role in other Plasmodium species for successful erythrocyte invasion.
Results
Variable dependence on BSG for human erythrocyte invasion by three
human malaria parasite species
It has been demonstrated that BSG is an essential receptor for erythrocyte invasion by all tested
P. falciparum strains, by blocking its binding function with either antibodies or soluble BSG
[13,27]. Here, we investigated the importance of BSG as a receptor for erythrocyte invasion by
P. knowlesi and P. vivax. Assays using P. knowlesi A1-H.1 merozoites [28] showed inhibition
of invasion by heparin, but no inhibition by either an anti-BSG mouse mAb (MEM-M6/6) or
soluble BSG at concentrations that severely inhibit P. falciparum invasion (Fig 1A and 1B). In
growth inhibition assays (GIAs) over 48 h, increasing concentrations of three different anti-
BSG antibodies (MEM-M6/6, TRA-1-85, and goat anti-BSG polyclonal IgG) all failed to
Role of CyRPA and RIPR in human-infective malaria parasites
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Fig 1. Role of basigin (BSG) as a receptor for erythrocyte invasion by P. falciparum, P. knowlesi and P. vivax. (A) Merozoite invasion
inhibition assay in the presence of anti-BSG mAb MEM-M6/6 or BSG protein for P. falciparum and (B) P. knowlesi. Late schizonts of P.
falciparum and P. knowlesi were manually ruptured and the merozoites added to fresh erythrocytes, either with no additives, with heparin,
MEM-M6/6, or BSG. Invasion was quantified after 12 h using flow cytometry. Three independent experiments were performed for P.
falciparum and two for P. knowlesi in triplicate. Invasion is normalised to the RPMI medium alone control, and mean and standard deviation
are displayed. (C) Growth inhibition assay (GIA) using schizont cultures of P. falciparum and (D) P. knowlesi in the presence of serial
dilutions of anti-BSG mouse mAbs MEM-M6/6 and TRA-1-85, anti-BSG goat polyclonal IgG, anti-DARC CA111 nanobody as well as non-
specific mouse and goat IgG (legend in box on the right of plot D). Parasitemias of three independent experiments in triplicate were measured
Role of CyRPA and RIPR in human-infective malaria parasites
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inhibit P. knowlesi invasion and growth (Fig 1D). Nanobodies against the Duffy antigen recep-
tor for chemokines (DARC), CA111 [29], inhibited growth severely with a half-maximum
inhibitory concentration (IC50) of 0.15 μg/ml. The reliance of P. knowlesi on DARC as an inva-
sion receptor has been well documented [10,30]. In parallel, the growth of P. falciparum (3D7)
was severely inhibited in a dose-dependent manner by all three anti-BSG antibodies (Fig 1C)
with IC50 values of 0.41 μg/ml (MEM-M6/6), 0.23 μg/ml (TRA-1-85) and 0.61 μg/ml (goat
anti-BSG polyclonal IgG). The anti-DARC nanobody was not inhibitory, and neither were
non-specific mouse and goat IgG.
We next investigated the role of BSG in invasion by P. vivax. Ten primary human isolates
of P. vivax were tested in an invasion inhibition assay with 10 μg/ml of anti-BSG mAb
MEM-M6/6, or goat anti-BSG polyclonal IgG (Fig 1E). Non-specific mouse and goat IgG at
the same concentration were used as negative controls. Whereas non-specific IgGs had no
effect on growth rates, both anti-BSG antibodies inhibited invasion of most isolates to varying
degrees. Some isolates were inhibited by >90% (Pv025) whereas others showed little or no
inhibition (Pv033). The differences in median parasitemia (S1 Fig) between control and anti-
BSG antibody treatments were significant (p<0.01). However, the variable inhibition profile
across different isolates suggests that P. vivax is not reliant on BSG as a host receptor, but
rather may use BSG as one of several alternative receptors, which can be used by different para-
site isolates to invade erythrocytes, a concept well known from P. falciparum [31–33]. As such,
these data demonstrate that unlike P. falciparum, neither P. knowlesi nor P. vivax is reliant on
BSG as a receptor for human erythrocyte invasion, suggesting that the absolute requirement
for BSG engagement evolved in the Laverania subgenus with the emergence of RH5.
RIPR and CyRPA are essential for P. knowlesi growth
RIPR and CyRPA are conserved across all or most Plasmodium species, (S2 Fig) with cyrpa
absent from P. berghei and other rodent-infective Plasmodium parasites. Comparing mRNA
expression profiles of ripr and cyrpa across species (RNAseq data from [34]) showed that both
genes, and rh5 (in P. falciparum only), are transcribed during blood-stage schizogony in P. fal-
ciparum, P. vivax and P. knowlesi (S3 Fig).
The function of CyRPA and RIPR in the life cycle of Plasmodium spp. other than P. falcipa-
rum is undefined. Given the importance of PfRIPR and PfCyRPA, possibly in rhoptry release
and Ca2+ signaling in the host cell, we sought to determine the effect of reducing or abolishing
expression of their P. knowlesi orthologues. We investigated whether disruption of ripr and
cyrpa in P. knowlesi is feasible. Using a newly developed CRISPR/Cas9 gene modification vec-
tor, we attempted to disrupt ripr and cyrpa by insertion of a triple-HA epitope tag followed by
a stop codon in each ORF, or as control, replacing the same region with recodonized DNA
sequence (Fig 2A and 2C). A 48 bp sequence of ripr was successfully replaced by recodonized
sequence in duplicate experiments using two independent guides (Fig 2B, primer pairs a/e
and f/d) whereas integration of the epitope tag with stop codon was unsuccessful (Fig 2B,
primer pairs a/h and g/d). Similarly, replacement of a 36 bp region of cyrpa with recodonized
sequence was successful in duplicate experiments using two guides (Fig 2D, primer pairs i/m
40 h after setup using flow cytometry. Mean and standard error are displayed. (E) Invasion inhibition assay using anti-BSG antibodies on field
isolates of P. vivax. Blood samples were taken from patients in Peru, matured to schizont stage in vitro and incubated with anti-BSG mAb
MEM-M6/6 and anti-BSG goat polyclonal IgG, as well as non-specific mouse IgG and goat IgG at 10 μg/ml. Ring stage parasitemia was
determined by microscopy of Giemsa-stained blood smears. The relative parasitemia (in %) is displayed for each individual sample compared
to control treatment of the same sample. Color-coding highlights the same patient samples treated with either of the anti-BSG antibodies.
https://doi.org/10.1371/journal.ppat.1007809.g001
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Fig 2. RIPR and CyRPA are essential for P. knowlesi parasite growth. Schematics of disruption approaches for ripr (A) and cyrpa (C) in P. knowlesi,
respectively. ORFs are depicted, indicating regions used as homology regions (HR) in repair plasmids. Black boxes represent endogenous DNA sequence
(bp 1006–1054 (ripr) and 372–408 (cyrpa)) which was replaced either by recodonized DNA or by a triple HA-tag followed by a stop codon. Sequence details
are given in the corresponding boxes below, of endogenous (wild type), recodonized DNA or HA-STOP regions. Primers used in PCR to genotype
transfectants are indicated by arrows. B) Genotyping of PkA1-H.1 transfections with pGEMT-PkRIPRko or pGEMT-PkRIPRrecodonized with pDC596
and pDC645 Cas9/guide plasmids. D) Genotyping of PkA1-H.1 transfections using pGEMT-PkCyRPAko or pGEMT-PkCyRPArecodonized together with
Cas9/guide plasmids pDC2915 or pDC2919. Primers for genotyping (S2 Table) were as follows: a, PKRIPRkoextFor; b, PKRIPRintRev; c, PKRIPRintFor;
d, PKRIPRkoextRev; e, PKRIPRkorecRev; f, PKRIPRkorecodFor; g, HArev(Xma); h, HAfor(Xma); i, PKCyRPAextFor; j, PKCyRPAintRev; k,
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and n/l) but not replacement with a reporter-stop sequence (Fig 2D, primer pairs i/h and g/l).
This strongly implies that Pkripr and Pkcyrpa disruption leads to non-viable parasites.
RIPR forms a novel CyRPA-independent complex in P. knowlesi
To explore whether PkCyRPA and PkRIPR form a complex in the absence of RH5 in P. know-
lesi, we generated a transgenic PkRIPR-HA-tagged P. knowlesi line (Fig 3A). Successful inte-
gration was confirmed by PCR (Fig 3B) and Southern Blot analyses (Fig 3C). Immunoblotting
of purified late schizont stages, probed with an anti-HA antibody (3F10), revealed the expected
~120 kDa PkRIPR-HA band, and a ~60 kDa band (Fig 3D). The presence of the smaller band
suggests PkRIPR is processed like PfRIPR [19], probably between the two clusters of EGF
domains (S2 Fig).
In P. falciparum, PfRIPR is present in the micronemes and following secretion forms the
trimeric complex with PfRH5 and PfCyRPA [19,20]. Indirect immunofluorescence assays
(IFAs) using anti-HA antibodies and the PkRIPR-HA parasite clone G4 showed an apical
localization for PkRIPR-HA in late-stage schizonts (Fig 3E). Co-localization experiments with
antibodies to PkAMA1, a micronemal protein, confirmed that PkRIPR-HA is likely microne-
mal. Following micronemal secretion, PkAMA1, a type 1 transmembrane protein, is present
on the merozoite surface, while the immunofluorescence signal for PkRIPR-HA is lost (Fig
3E); PkRIPR, like PfRIPR, lacks any membrane-anchoring domain. These data suggest that
PkRIPR and PfRIPR have a conserved localization in the micronemes. PfRIPR has been shown
to be released onto the merozoite surface at invasion and follows the moving junction as the
merozoite invades [19,21]. The signal of PkRIPR is lost from purified merozoites after micro-
neme secretion (visualized by the fluorescence signal of anti-AMA1 changing from apical dots
to a circle outlining the merozoite surface).
To determine whether PkCyRPA and PkRIPR interact in P. knowlesi, we conducted co-
immunoprecipitation experiments using two different anti-HA matrices to purify PkRIPR-HA
and interacting proteins, following the same approach used with P. falciparum [19]. Immuno-
precipitations from extracts of purified schizonts or concentrated culture supernatant from
PkRIPR-HA parasites gave comparable results. Two proteins were consistently identified by
LC-MS/MS in the co-precipitate with PkRIPR-HA (Fig 3F, S1 Dataset); however, PkCyRPA
was not found. The two identified proteins have a predicted signal peptide, and their gene
transcription profiles are similar to that of PkRIPR, upregulated late in schizogony. These pro-
teins are P. knowlesi PTRAMP (PKH_143510) and a hypothetical protein (PKH_134220) that
is conserved within the genus and which we term cysteine-rich, small, secreted protein (CSS)
here. No information is available about orthologues of Pkcss except that css has an essential
role in the asexual blood stage of P. falciparum [35]. PTRAMP, a member of the thrombospon-
din-related anonymous protein (TRAP) family, is located apically in P. falciparum merozoites
[36], and is essential for P. berghei and P. falciparum blood-stage development [35,37,38].
PfPTRAMP is a type 1 membrane protein that is transferred to the merozoite surface where it
forms a dimer. The subtilisin-like protease PfSUB2 cleaves PfPTRAMP from the merozoite
surface during invasion releasing the protein into the culture supernatant [39]. Analysing pep-
tide sequences identified by LC-MS/MS from these co-immunoprecipitations revealed that
PkPTRAMP peptides ELYENVAGR and GAEKELYENVAGR derived from the cytoplasmic
C-terminus were only detected in PkRIPR-HA precipitates from schizont lysates, not in
PKCyRPAintFor; l, PKCyRPAextRev; m, PKCyRPArecodRev; n, PKCyRPArecodFor. Expected PCR product sizes for Pkripr are: a/b = 426 bp; a/e = 434 bp;
c/d = 412 bp; f/d = 418 bp; a/h = 509 bp; g/d = 499 bp. Expected PCR product sizes for Pkcyrpa are: i/j = 425 bp; i/m = 438 bp; k/l = 566 bp; n/l = 570 bp;
i/h = 504 bp; g/l = 654 bp.
https://doi.org/10.1371/journal.ppat.1007809.g002
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Fig 3. HA-tagging, localization and complex formation of PkRIPR. (A) Schematic of single homologous recombination to generate C-
terminally tagged parasite line, PkRIPR-HA. (B) Integration PCRs using genomic DNA from PkA1-H.1 (PK wt) parasites or PkRIPR-HA parasite
clones I1 and G4. Using the primer pair PkRIPRextF1/PkRIPRutrRev, a 1595 bp fragment was amplified from wild type parasites, whereas primer
pair PkRIPRextF1/HArev amplified a 1526 bp fragment only from transgenic PkRIPR-HA parasites. Positions of primer pairs are indicated in
schematic (A) and size standards (kb) on the left of the gel (B). Primers used were PkRIPRextF1 (1), PkRIPRutrRev (2), HArev (3). (C) Southern
blot of wildtype and transgenic parasite DNA digested with EcoRV/AvaI. Endogenous locus band, integration and episomal bands are indicated
with arrows. (D) Immunoblot of purified schizont material solubilized in Laemmli sample buffer probed with anti-BiP and anti-HA (3F10)
antibodies. Molecular mass standards are indicated on the left in kDa. (E) IFAs of schizonts and merozoites with micronemes not secreted (2nd
row) or secreted (3rd row) were probed with anti-HA antibody (green), anti-PkAMA1 antibody, or anti-PkRhopH2 antibody (both red) and DAPI
(Blue). The third panel shows an overlay of DAPI marking the nucleus with anti-HA and anti-PkAMA1; the fourth panel includes a differential
interference contrast (DIC) image of the whole parasite. Scale bar = 2 μm. (F) Table of proteins interacting with PkRIPR-HA as identified by
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precipitates from culture supernatant. In contrast, peptide ETRPCQVPLPPCNSLFELK
derived from the extracellular domain just N-terminal to the predicted transmembrane
domain of PkPTRAMP was detected in both. This demonstrates that, in the absence of RH5,
RIPR is associated with an entirely different, trimeric protein complex in P. knowlesi, lacking
CyRPA and any RH5-like protein, with PkPTRAMP likely anchoring this new trimeric com-
plex to the merozoite surface.
The PkRIPR trimeric protein complex and PkCyRPA are essential for
successful erythrocyte invasion
To investigate in more detail when and where during the parasite’s asexual blood stage the
newly identified PkRIPR-PkPTRAMP-PkCSS complex as well as PkCyRPA function, we gen-
erated an inducible gene knockout (iKO) system for P. knowlesi based on the DiCre recombi-
nase approach applied so successfully in P. falciparum [40]. For this we modified the pSKIP
vector [41] and targeted insertion of the DiCre cassette into the pfs47 homologue of P. know-
lesi, PKNH_1254100, using CRISPR-Cas9 guide plasmid pDC946. This resulted in the DiCre-
recombinase expressing cloned parasite line PkpSKIP9-10. Next we floxed endogenous genes
ptramp and css by inserting a loxPint cassette (see Materials and Methods for detail) down-
stream of the predicted signal peptide sequence and a loxP cassette following the stop codon
(S4 Fig). At the same time we inserted a triple HA-tag sequence between the predicted signal
peptide and the loxPint sequence. Transfectants were cloned by limiting dilution and clones
analyzed by PCR (S4 Fig). PCR products of inducible Pkptramp parasite clones were of
expected sizes (733 bp for primer pair 4/7 and 506 bp for primer pair 5/9) and no bands were
detected with primers amplifying wild type sequence (primer pair 4/6 expected wild type band
of 723 bp; primer pair 5/8 expected wild type band of 804 bp). Similarly, PCR product sizes of
inducible Pkcss parasites were as expected with primer pair 10/14 amplifying a 783 bp band,
and primer pair 11/15 a 613 bp band. Again, no bands corresponding to amplification of wild
type css sequence were detected (primer pair 10/12 expected wild type band of 484 bp; primer
pair 11/13 expected wild type band of 729 bp). Inducible knockout parasites for cyrpa were
generated by replacing the endogenous intron with the loxPint cassette and placing a loxP
sequence after the stop codon (S4 Fig). To detect PkCyRPA protein a triple HA-tag sequence
was encoded located 5’ to the stop codon. After limiting dilution cloning of transfectants, para-
sites were analyzed by PCR, showing integration bands for primer pair 16/19 of 577 bp and,
primer pair 17/21 of 904 bp (S4 Fig). No wild type DNA sequence for cyrpa could be detected
in the transgenic clones, whereas genomic DNA (PkpSKIP9-10) gave amplification products
of 641 bp with primer pair 16/18 and 670 bp with primer pair 17/20 as expected.
Having generated HA-tagged transgenic parasites we investigated the subcellular location
of PkPTRAMP, PkCSS and PkCyRPA in these lines. IFAs using anti-HA antibody 3F10
together with anti-AMA1 or anti-RhopH2 antibodies showed partial co-localization with the
micronemal marker (AMA1) but none with the rhoptry bulb marker RhopH2 (S5 Fig).
To confirm the formation of the PkRIPR-PkPTRAMP-PkCSS complex in schizonts of
P. knowlesi parasites and the absence of PkCyRPA from this complex we immunoprecipitated
HA-tagged parasite proteins from schizont lysates of PkptrampiKO, PKcssiKO and PKcyr-
paiKO, using 3F10 affinity matrix. Analysis of all co-immunoprecipitated proteins by LC-MS/
MS identified PkPTRAMP, PkRIPR and PkCSS as the three most abundant proteins from
LC-MS/MS following immunoprecipitation. The three top-scoring, consistently identified proteins are listed. The number of peptides of three
technical replicates of immunoprecipitates from PkRIPR-HA clone G4 or wild type parasites is displayed, as is the total peptide coverage, gene IDs
and annotations (PlasmoDB release 25).
https://doi.org/10.1371/journal.ppat.1007809.g003
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PkptrampiKO lysate (S2 Dataset). Equally, the same proteins were identified as most abundant
in the immunoprecipitation from PkcssiKO lysates. However, co-immunoprecipitation exper-
iments using the 3F10 matrix on PkcyrpaiKO schizont lysate only identified peptides derived
from CyRPA abundantly enriched compared to the negative control (S2 Dataset).
To study the phenotype of gene knockouts, synchronized ring stage parasites from two
clones of each inducible knockout line (ptrampiKO, cssiKO, cyrpaiKO) as well as the DiCre
recombinase-expressing P. knowlesi parasite line PkpSKIP9-10 were treated with DMSO or 10
nM rapamycin for 28 h. Recombination induced by the addition of rapamycin resulted in
complete excision of the floxed DNA sequence (Fig 4A) and loss of the protein as detected by
immunoblots labelled with anti-HA antibodies (Fig 4B). A significant reduction in protein
level for PkCSS and PkPTRAMP and complete lack of PkCyRPA can be seen in immunoblots
after rapamycin treatment. Also, these inducible knockout parasites failed to complete their
asexual life cycle as shown by invasion assay (Fig 4C). Rapamycin-treated PkpSKIP9-10 para-
sites however showed no invasion defect. Giemsa-stained thin blood smears (Fig 4D) clearly
demonstrate that merozoites of knockout parasites PkptrampiKO, PkcssiKO and PkcyrpaiKO
bound to the surface of human erythrocytes but failed to invade, unlike the DMSO-treated
transgenic lines or the rapamycin-treated PkpSKIP9-10 DiCre parasites.
We also addressed the role of PkRIPR, PkCSS and PkPTRAMP in host cell invasion by
invasion inhibition assays using rabbit antibodies generated against recombinant PkRIPR,
PkPTRAMP and PkCSS proteins (S6 Fig; Fig 4E). Whereas control, anti-PTRAMP, and anti-
CSS IgG at concentrations ranging from 0–2 mg/ml showed no reduction in parasitemia levels,
anti-RIPR IgG reduced parasitemia levels severely, with an IC50 value of 0.43 mg/ml. Together,
these data demonstrate the essential role the PkRIPR-PkPTRAMP-PkCSS complex plays dur-
ing host cell invasion.
PkPTRAMP binds to human erythrocytes
PfPTRAMP has previously been shown to bind to a receptor on the surface of human erythro-
cytes [36]. We used recombinant PkPTRAMP and PkCSS to investigate their potential to bind
to the surface of human erythrocytes (Fig 5). Recombinant His-tagged PfRH5 and PfMSP3
were used as positive and negative controls respectively. Immunoblots in Fig 5 show that bind-
ing to human erythrocytes was only detected with PkPTRAMP and RH5, but not PkCSS.
In summary, PkRIPR forms a complex with PkPTRAMP and PkCSS. This complex plays
an essential role during erythrocyte invasion by P. knowlesi merozoites, as does PkCyRPA. All
four proteins appear possibly to localize to micronemes, but in contrast to the situation in P.
falciparum PkCyRPA and PkRIPR work independently in P. knowlesi and therefore have likely
diverged in functional roles over the course of Plasmodium evolution.
Discussion
In this work, we set out to characterize the role of CyRPA and RIPR in P. knowlesi that lacks
an RH5 orthologue, and to investigate the use of BSG as a receptor for human erythrocyte
invasion in two important human malaria-causing agents, P. knowlesi and P. vivax.
The RH5-BSG interaction is essential for invasion in all strains of P. falciparum. PfRH5 has
been implicated in P. falciparum host cell tropism, with amino acid substitutions in both RH5
and BSG involved [11,42–44]. While the host cell specificity determinants for P. vivax and
P. knowlesi are largely unknown [7,45,46], we show here that BSG is not an essential require-
ment for erythrocyte invasion in these species.
With P. vivax field isolates, anti-BSG antibodies gave varying levels of growth inhibition,
and therefore BSG may be used as one of the alternative, redundant invasion receptors in
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Fig 4. Newly identified complex components PkRIPR, PkCSS and PkPTRAMP are essential for human erythrocyte invasion, as is PkCyRPA.
Inducible knockouts of pkcss, pkptramp and pkcyrpa were produced in the P. knowlesi DiCre expressing PkpSKIP 9–10 parasite line using CRISP/Cas9
gene editing. (A) PCR screen of wild type (pSKIP) and two clones of each transgenic parasite line (ptrampiKO, cssiKO, cyrpaiKO) showing successful and
complete recombination of floxed gene sequences after rapamycin addition (+). Primer pair 4/5 specific for the ptramp locus amplified a 1741 bp band in
wild type parasites, a 1993 bp band in mock -treated (-), transgenic parasites and a reduced size band of 965 bp after excision induced by rapamycin (+).
Primer pair 10/11 specific for the css locus amplified a 1761 bp band in wild type, a 2013 bp band in mock-treated, transgenic parasites and a 919 bp band
after excision. Primer pair 16/17 specific for the cyrpa locus amplified a 1467 bp band in wild type, a 1559 bp band in mock-treated and a 891 bp band in
rapamycin-treated, transgenic cyrpaiKO parasites. DNA marker sizes are shown on the left. (B) Immunoblot of schizonts purified 26 h after DMSO (-) or
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P. vivax, similar to a recently identified reticulocyte-specific transferrin-receptor 1 [47] in
P. vivax or glycophorins or CR1 in P. falciparum invasion [48–52]. PvTRAg5 (also known as
PvTRAg38) has been shown to bind to BSG [53], perhaps serving as a ligand in an invasion
pathway for some parasites.
Addressing the role of RIPR and CyRPA in the P. knowlesi asexual life cycle, we show that
both proteins are essential to parasite survival but do not interact with each other, suggesting
independent functions, unlike in P. falciparum. PkRIPR appears micronemal and interacts
with two new binding partners, PkCSS and PkPTRAMP, which were reproducibly co-immu-
noprecipitated. Both proteins are conserved throughout the genus. CSS is a small cysteine-
rich, secreted protein expressed during blood-stage schizogony, and its P. falciparum ortholo-
gue appears essential for parasite growth [35]. PTRAMP is an apical protein [38] essential in
blood-stage development of P. berghei and P. falciparum [35,37]. In P. falciparum the protein
is transferred to the merozoite surface as a membrane-bound dimer before cleavage by SUB2
to release a soluble product [39]. Further, PTRAMP has been reported to bind directly to
erythrocytes, and anti-PTRAMP antibodies partially inhibit invasion at high antibody concen-
trations [36].
By developing an inducible gene regulation approach for P. knowlesi and by generating
invasion inhibitory antibodies we could show that the PkRIPR-PkPTRAMP-PkCSS complex
functions during invasion of host erythrocytes. The invasion assay using antibodies against all
three complex components only showed inhibition of invasion with anti-RIPR antibodies.
Anti-RIPR antibodies were raised to two small regions of PkRIPR homologous to regions in
PfRIPR which previously showed potential as targets for growth inhibition of P. falciparum
[19]. Antibodies against PkCSS and PkPTRAMP did not inhibit invasion. Given that we have
rapamycin (+) treatment of ring stage cultures from wild type (pSKIP) and inducible knockout parasite lines. Two clones are shown for each knockout
parasite. Blots were probed with anti-HA and anti-BiP antibodies as indicated on the right of the panels. All protein signals correspond approximately with
their predicted molecular masses (HA-tagged PkCSS has a predicted molecular mass of 40.6 kDa, HA-tagged PkPTRAMP a predicted molecular mass of
39.2 kDa and PkCyRPA-HA a predicted mass of 42.5 kDa). Molecular mass standards are indicated on the left. (C) Invasion assay of wild type and
inducible knockout parasites lines over one growth cycle. Parasitemias were measured by flow cytometry 40 h after rapamycin / DMSO treatment. Means
and standard errors of three independent experiments carried out in triplicate are displayed. (D) Giemsa-stained brightfield images of wild type and
inducible knockout parasites 30 h after DMSO (-) or rapamycin (+) treatment. Arrowheads point to merozoites attached to erythrocytes which have failed
to invade. Scale bars equal 2 μm. (E) Growth inhibition assay of PkA1-H.1 parasites over one cycle with serial dilutions of purified IgG raised against
recombinantly produced PkPTRAMP, PkCSS, PkRIPR or control rabbit IgG. Parasitemias were determined by flow cytometry 18 h after assay setup at
schizont stage. Means and standard errors of three independent experiments in triplicate are displayed.
https://doi.org/10.1371/journal.ppat.1007809.g004
Fig 5. Erythrocyte binding assay demonstrating the ability of PTRAMP but not CSS to bind to receptors on the erythrocyte surface. Increasing
amounts of recombinant proteins (in μg) were incubated with human erythrocytes, before repeated separation steps through oil and elution of bound
protein. Immunoblots of eluted proteins are shown, probed with anti-His antibody. Recombinant RH5 and MSP3 were used as positive and negative
controls respectively. Molecular mass standards are indicated on the left of each panel (in kDa).
https://doi.org/10.1371/journal.ppat.1007809.g005
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shown that PkPTRAMP can bind to human erythrocytes, it was expected that specific antibod-
ies would prevent this binding and be invasion inhibitory. It is possible that these proteins are
not accessible to antibody during invasion, or that higher antibody concentrations are
required, as seen with anti-PTRAMP antibodies in P. falciparum [36]. We have previously
shown that DiCre recombinase-mediated gene excision after rapamycin addition takes >24 h
to achieve ~80% excision levels in P. falciparum [40]. On immunoblots small amounts of
PkCSS and PkPTRAMP are visible after rapamycin treatment (Fig 4B) although DNA excision
appears complete. We presume that after rapamycin treatment the small number of ring stage
parasites in the invasion assays (Fig 4C) reflects the residual protein level seen in the immuno-
blots and that during the ~28 h life cycle of P. knowlesi not all floxed genes in each parasite
were excised prior to translation initiation.
For PkCyRPA, no binding partners were identified. However, like the PkRIPR-PkP-
TRAMP-PkCSS complex, PkCyRPA is important in host cell invasion, as shown here using
the inducible gene knockout approach. Given that PkCyRPA acts independently of PkRIPR
and that BSG is not a receptor for host cell entry by P. knowlesi, CyRPA has a different role
during invasion in P. falciparum compared to P. knowlesi. This change of function during evo-
lution is likely a consequence of the acquisition of both rh5 and cyrpa by P. falciparum via hori-
zontal gene transfer from a gorilla-infective P. alderi parasite [25,26]. This transfer resulted in
a conserved synteny and presumably functionality of cyrpa and rh5 only in Laverania species.
Summarizing our data, we present a model of the different, essential roles of RIPR, CyRPA,
and RH5 during erythrocyte invasion by P. knowlesi and P. falciparum (Fig 6A and 6B, respec-
tively). In P. knowlesi, BSG engagement is not required during invasion of human erythro-
cytes. PkRIPR forms a complex with membrane-bound PkPTRAMP and a conserved,
uncharacterized protein we named PkCSS (Fig 6A). This complex is involved in invasion, pre-
sumably mediating host cell recognition by interaction of PkPTRAMP with an unknown host
cell receptor. PfPTRAMP is shed during invasion [39]. PkPTRAMP and PfPTRAMP are
highly conserved, and peptides corresponding to the cytoplasmic C-terminus of PkPTRAMP
were identified in immunoprecipitations from parasite schizont lysates, but not from culture
supernatant, leading us to suggest that PkPTRAMP is similarly shed during invasion of P.
knowlesi releasing the trimeric PkRIPR-PkPTRAMP-PkCSS complex from the merozoite sur-
face. Whether or not PkRIPR integrates into the erythrocyte membrane as described for P. fal-
ciparum [24] is unclear. PkCyRPA, meanwhile, also localizes to micronemes and is involved in
erythrocyte invasion, but no interaction partners have been identified for this protein. This is
unlike the situation in P. falciparum where CyRPA forms a complex with RIPR and RH5 and
BSG engagement is required during invasion of human erythrocytes. In P. falciparum, PfRH5
is present in the rhoptry neck, while RIPR and CyRPA are in micronemes, and following
release early in invasion, the proteins form a trimeric complex that interacts with erythrocyte
surface BSG (Fig 6B). Following binding to BSG, RIPR and RH5 form multimers which insert
into the erythrocyte membrane [24]. By an unknown mechanism this results in Ca2+ influx
into host erythrocyte, a process deemed important for invasion. PfPTRAMP and PfCSS appear
to play no known role in the PfRH5-CyRPA-RIPR-BSG interaction, but might have a different,
undiscovered role in invasion.
Ligand-receptor interactions involved in the initiation of invasion as well as the final step,
moving junction formation, are conserved between Plasmodia. From our work, it appears that
the presumed trigger for rhoptry secretion, a universally important invasion step, is species-
specific, with the RH5-CyRPA-RIPR complex fulfilling this role only in Laverania parasites.
With vaccine development in mind, understanding the critical steps and essential immuno-
gens of host cell invasion across Plasmodium species is critical for the design of malaria inter-
vention strategies.
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Fig 6. A cartoon depicting invasion of (A) P. knowlesi or (B) P. falciparum merozoites into human erythrocytes. P. knowlesi lacks an
RH5-like molecule, resulting in the secretion of RIPR complexed with PkPTRAMP and PkCSS. The precise role of this complex in the
invasion process is currently unknown but we speculate that PkPTRAMP as a transmembrane protein is both displaying PkRIPR and
PkCSS on the merozoite surface after microneme release and is recognizing a receptor on the human erythrocyte, which is an important
step required for successful invasion. BSG is not used as a human erythrocyte receptor by P. knowlesi. In stark contrast, P. falciparum
RH5 and the micronemal proteins PfRIPR and PfCyRPA form a trimeric complex following rhoptry neck and microneme secretion. This
complex localizes to the merozoite surface, through an interaction between the N-terminus of RH5 and GPI-anchored protein P113, and
connects the parasite via BSG to the host erythrocyte. This interaction between RH5 and BSG is speculated to result in rhoptry bulb
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Materials and methods
Ethical statement
Ethical approval for the collection of P. vivax isolates from infected patients in Peru was
obtained from the Institutional Ethics Committees of the Universidad Peruana Cayetano
Heredia, Lima, Peru. Ethical approval for the use of P. vivax isolates and collection of blood
samples from hemochromatosis patients was obtained from the Ethics Committee of the Insti-
tute of Tropical Medicine (ITM), Antwerp, Belgium (946/14).
Parasite culture
P. falciparum was maintained in human erythrocytes using standard conditions [54]. P. know-
lesi was maintained using a modified complete RPMI 1640+AlbumaxII medium supplemented
with 10% horse serum [55].
Genetic modification of parasites and genotyping
The Pkripr gene was modified by addition of sequence coding for a C-terminal epitope tag.
For this, we used a modified PkconGFP vector [56,57], carrying a triple HA-tag. A 1331 bp
region of PkRIPR was amplified using primers pHH4RIPRfor/rev and cloned into
pHH4PkHA using XmaI/AvrII. The resulting plasmid was linearized using PmlI and trans-
fected into PkA1-H.1 as described [57].
For genotyping, we employed diagnostic PCR, Southern blotting and immunoblotting
approaches. For Southern blots, wild type and transgenic parasite genomic DNA was digested
using EcoRV/AvaI. Fragments were separated by agarose gel electrophoresis and transferred
to a nitrocellulose membrane before hybridization with a 32P-labelled PkRIPR-specific 1331
bp probe amplified using primer pair pHH4RIPRfor/rev. All primer sequences are listed in S2
Table. For immunoblotting, purified schizont and merozoite samples were solubilized in
reducing sample buffer and proteins were resolved on NuPAGE Tris-Acetate or Bis-Tris gels
before transfer to nitrocellulose membranes. Membranes were probed with anti-HA 3F10
mAb and anti-BiP rat antibodies, and detected using ECL.
The CRISPR-Cas9 vector for use in P. knowlesi, pDC2-PK-Cas9-hDHFRyFCU (S7 Fig) was
generated by digestion of the P. falciparum CRISPR/Cas9 vector pDC2-Cas9-hDHFRyFCU
[40] with NcoI/AvrII to replace the promoters driving cas9 and the hdhfr-yfcu transcription
with P. knowlesi specific promoters. For this, 5’UTR regions of Pkhsp86 and Pkef1alpha were
amplified using primer pairs Pkhsp86promforNcoSpeI/Pkhsp86promRevAvrII and Pkef1aFor
(SpeI)/Pkef1aRev(NcoI) from P. knowlesi genomic DNA before digestion and ligation into
pDC2-Cas9-hDHFRyFCU. Finally, the U6 cassette was replaced with a synthetically generated
DNA construct comprising 632 bp of 5’UTR of the P. knowlesi U6 spliceosomal RNA gene
PKNH_1260300 and 100 bp of its terminator sequence flanking the tracrRNA and BbsI site
for protospacer insertion.
Guide RNA sequences were identified using Protospacer software (http://www.
protospacer.com/) and cloned into pDC2-PK-Cas9-hDHFRyFCU as described [40]. Repair
DNA plasmids were synthesised and cloned into pGEMT-Easy vector. For disruption of ripr,
DNA strings were synthesised corresponding to bp 661–1006 and bp 1054–1398 of the
secretion and Ca2+ influx into the host cell. RH5 and RIPR have been postulated to multimerize and integrate into the erythrocyte
membrane, which by an unknown mechanism results in the influx of Ca2+ into the host cell. This is followed by the formation of the
moving junction. The RH5 complex follows the moving junction, from the apical tip of the merozoite to its posterior end, setting in
motion the irreversible process of active invasion of the host cell by the merozoite.
https://doi.org/10.1371/journal.ppat.1007809.g006
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endogenous ripr and were linked by either a recodonized 48 bp DNA sequence (pGEMT-Pk-
RIPRrecodonized) or an XmaI site (pGEMT-PkRIPRXmaI). The triple HA tag with a stop
codon was amplified by PCR using primer pair HAfor(XmaI)/HArevXmastop and plasmid
pHH4PkRIPR-HA. The triple HA tag was inserted into pGEMT-PKRIPRXmaI resulting in
pGEMT-PkRIPRko. Similarly, DNA strings for cyrpa were synthesised comprising endoge-
nous DNA sequences 219–573 bp and 609–1109 bp being either linked by 36 bp of recodo-
nized DNA sequence or an XmaI site and cloned into pGEMT-Easy vector resulting in vectors
pGEMT-PkCyRPArecodonized and pGEMT-PkCyRPAXmaI. Finally, insertion of the triple
HA-tag comprising a stop codon into the XmaI site generated plasmid pGEMT-PkCyRPAko.
20 μg of guide plasmid and 60 μg of EcoRI-linearized repair plasmids were transfected into
nycodenz-purified PkA1-H.1 late schizonts. Transfected parasites were selected with 50 nM
pyrimethamine for 3 days. Parasites derived from CRISPR/Cas9 transfection were analyzed by
PCR.
For the generation of a DiCre-expressing PkA1-H.1 parasite line we generated the
PkpSKIP_Pk47 vector (S8 Fig), by replacing the crt promoter in pSKIPFlox [41] with 859 bp
of Pkhsp86 promoter amplified from pDC2-PK-Cas9-hDHFRyFCU using primers
Pkhsp86promFBglSac and Pkhsp86promrevXho. We then amplified 500 bp of the pfs47
homologue in P. knowlesi (PKNH_1254100) using primer pair PK47HR1for2BglII /
PK47HR1rev2SacII and cloned this fragment upstream of the Pkhsp86 promoter using restric-
tion enzymes BglII and SacII. We further amplified a second, 385 bp homology region from
PKNH_1254100 using primer pair PK47HR2forEcoRV / PK47HR2rev2short and cloned this
fragment into the EcoRV-digested vector downstream of the PbDT3’ UTR sequence.
A guide plasmid targeting PKNH_1254100 was generated by cloning annealed and phos-
phorylated primer pair pDC946For / pDC946Rev into pDC2-PK-Cas9-hDHFRyFCU. 20 μg of
guide plasmid pDC946 was transfected together with 110 μg of BglII and BtgZ1-linearized
PkpSKIP_Pk47 repair plasmid. Resulting transfectants were cloned by limiting dilution and
analyzed by PCR and DNA sequencing. All work using DiCre recombinase-expressing P.
knowlesi parasites was carried out on clone PkpSKIP9-10.
To flox and epitope tag the ORFs of Pkptramp, Pkcss and Pkcyrpa synthetic repair DNA
plasmids were synthesized by GeneArt (Thermo Fisher Scientific). For the Pkptramp repair
plasmid (pMKPkptrampiKOrepair), 290 bp of promoter together with 28 bp of ORF sequence
were used as homology region 1 followed by 44 bp of recodonized ORF sequence before the
insertion of a triple HA-tag and a loxPint sequence based on the intron 4 sequence of Pkdbpal-
pha (S8 Fig), followed by the remaining 948 bp of recodonized ORF sequence, a loxP sequence
after the stop codon, and 310 bp of 3’ UTR region functioning as homology region 2. The
Pkcss repair plasmid (pMKPkpcssiKOrepair) was designed of 300 bp of css promoter and
55 bp of 5’ ORF sequence functioning as homology region 1, 14 bp of recodonized DNA
sequence, a triple HA-tag, a loxPint insertion, 1014 bp of recodonized ORF sequence, a loxP
site after the stop codon and 311 bp of 3’ UTR sequence which functioned as homology region
2. For the Pkcyrpa repair plasmid (pMKPkcyrpaiKOrepair) DNA sequence corresponding to
nucleotides 273–603 of cyrpa functioning in this plasmid as homology region was synthesized
and is followed by recodonized ORF sequence (11 bp), loxPint, the remaining 484 bp of C-ter-
minal ORF sequence which was recodonized, a triple HA-tag, a stop codon, a loxP sequence
and 323 bp of 3’UTR sequence. As before the 3’UTR sequence is used as the region in the
homologous recombination DNA repair step following DNA cleavage by Cas9 nuclease.
We transfected PkpSKIP9-10 DiCre recombinase expressing parasites with 60 μg of repair
plasmids together with 20 μg of each of two guide RNA plasmids (pMKPkptrampiKOrepair
with pDC45+pDC982; pMKPkpcssiKOrepair with pDC89 + pDC1081; pMKPkcyrpaiKOre-
pair with pDC591+pDC1229). Locations of guide RNAs were chosen in order to direct DNA
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cleavage close to either of the two homologous recombination flanks (see S4 Fig). Transfected
parasites were selected with 50 nM pyrimethamine for 4 days. Parasites derived from these
CRISPR/Cas9 transfections were cloned by limiting dilution and validated by PCR and
immunoblotting.
Protein expression and purification
For recombinant PkPTRAMP and PkCSS expression, full-length, codon-optimized
(for human expression) ORFs lacking the signal sequence were synthesized (encoding resi-
dues Val20 –Ala362 of PkCSS and residues Asp20-Phe296 of PTRAMP). The genes were
cloned into the pHLsec vector [58] using KpnI and AgeI. Expi293F cells (Thermo Fisher Sci-
entific) were transfected with these constructs and culture supernatant harvested after 6
days.
For PkRIPR expression, two gene fragments were synthesized, corresponding to PfRIPR
fragments previously successfully expressed [19]: an N-terminal fragment (PkRIPR residues
Lys287-Glu371) and a C-terminal fragment (residues Asp741-Asp850). The gene fragments
were cloned into a modified pET15b vector (Novagen) and the resultant plasmid transformed
into Shuffle cells (NEB). Expression was induced and the cells incubated at 30˚C for 16 h,
before harvesting and lysing of the cells by sonication.
Recombinant PkPTRAMP, PkCSS, and PkRIPR proteins were purified by affinity chroma-
tography using nickel-nitrilotriacetic acid resin (Ni2+-NTA). The eluate was concentrated
(Amicon Ultra centrifugal filter; MWCO 10 kDa) and gel filtered using a Superdex 200 16/60
column (PkPTRAMP and PkCSS) or a Superdex 75 16/60 column (PkRIPR; GE Healthcare),
in 20 mM HEPES, 150 mM NaCl, pH 7.5.
Antibody production
For anti-PkRIPR, anti-PkPTRAMP and anti-PkCSS antibodies, rabbit immunizations were
carried out by Covalab in compliance with the UK Animals (Scientific Procedures) Act. Rabbit
antibodies against PkRIPR were raised against the combination of two recombinant proteins
as described above.
Erythrocyte binding assays
Erythrocytes were washed in RPMI 1640 medium. 50 μl packed erythrocytes were added to
45 μg, 15 μg, 5 μg, 1.67 μg, or 0 μg of recombinant protein in 150 μl RPMI 1640 medium.
Recombinant proteins tested were PkPTRAMP, PkCSS, PfMSP3 and full-length PfRH5 [16].
The samples were incubated at room temperature for 1 h with gentle shaking. Thereafter, sam-
ples were separated through dibutyl phthalate, washed and bound protein eluted with 20 μl of
1.5 M NaCl. Input protein and the eluate were analyzed by immunoblot probed with anti-His
antibodies.
Immunofluorescence assays
Indirect immunofluorescence assays (IFAs) were performed on purified schizonts, merozoites
and early ring stages of PkRIPR-HA clone G4 as well as on mature schizonts of PkptrampiKO,
PkcssiKO and PkcyrpaiKO clones. IFAs were carried out as described [59] using mAb 3F10
anti-HA, rabbit anti-PkAMA1, and mouse anti-PkRhopH2 antibodies and visualized using a
Nikon Eclipse Ni microscope 100x Plan Apo λ NA 1.45 objective. Images were collected using
an Orca Flash 4 digital camera controlled by Nikon NIS Elements AR 4.30.02 software.
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Invasion and growth inhibitory antibody assays (GIA)
Invasion assays for P. falciparum and P. knowlesi merozoites were carried out as described
[28,60]; for P. knowlesi, a 3 μm filter was followed by a 2 μm filter (Whatman) to release mero-
zoites. Merozoites were added rapidly to erythrocytes and any additives, at 1% final hemato-
crit. Additives were anti-BSG mAb MEM-M6/6 (ThermoFisher) and soluble BSG [16]. The
final heparin concentration used to inhibit invasion was 71.4 mU/μl for P. falciparum, and 125
mU/μl for P. knowlesi. After 12 h, cells were washed in PBS, stained with SybrGreen and ana-
lyzed by flow cytometry.
For invasion inhibition assays with anti-PkRIPR, anti-PkCSS, and anti-PkPTRAMP anti-
bodies, synchronized populations of schizont-stage PkA1-H.1 parasites were added to erythro-
cytes in the presence of a serial dilution of purified IgG from 2 mg/ml. As control, nonspecific
rabbit IgG was used (Sigma). After 18 h, cells were stained with SybrGreen and parasitemia
was analyzed by flow cytometry.
Growth inhibition assays using anti-BSG and anti-DARC antibodies were carried out with
P. falciparum 3D7 and P. knowlesi A1-H.1 lines, and P. vivax field isolates. The antibodies used
were anti-BSG mAbs MEM-M6/6 and TRA-1-85 (R&D Biosystems); anti-human CD147
goat polyclonal antibody (R&D Biosystems); anti-DARC nanobody CA111 (a kind gift from
Olivier Bertrand and Yves Colin); non-specific mouse IgG (Sigma); and non-specific goat
IgG (R&D Biosystems). P. falciparum and P. knowlesi GIAs were carried in complete RPMI
1640+AlbumaxII and supplemented with 10% horse serum, at 2% hematocrit. Synchronized
populations of schizont-stage parasites were incubated with a serial dilution of antibodies
from 20 μg/ml; after 40 h, cells were fixed, stained with Hoechst 33342 and parasitemia was
measured by FACS.
P. vivax invasion assays were carried out with isolates taken from patients with acute infec-
tion from communities close to Iquitos city in Peru. Ten ml samples of blood were collected
from patients with single P. vivax malaria infections and a parasite density of>0.1%. Platelets
and leukocytes were depleted from samples with�80% parasites at the ring or trophozoite
stages, using a CF11 column [61]. After P. vivax maturation invasion assays were performed in
96-well plates as previously described [62,63] using reticulocyte-enriched (>50%) erythrocyte
preparations. Reticulocytes were purified from blood samples of hemochromatosis patients
within 48 h of collection. These samples were typed for the Duffy phenotype (Fy) using stan-
dard serological methods (DiaMed-ID Micro Typing Systems, DiaMed), and leukocytes
removed using filters (Fresenius Kabi), before enrichment of reticulocytes by differential cen-
trifugation [64] followed by Percoll gradient [62]. Antibodies were tested at 10 μg/ml for inva-
sion assays. Assays were set up at a 1:6 ratio of parasite to reticulocyte enriched RBCs (as
described [63]) and invasion inhibition was measured in paired samples using the same para-
site isolates (a total of 10). For valid invasion assays, the parasitemia of the untreated control
was�0.5% (S1 Table). Level of invasion was analyzed by microscopy and calculated as the per-
centage of ring stage parasite-infected erythrocytes 24 h post-invasion, counting >9000 eryth-
rocytes. Statistical analysis was performed using Wilcoxon matched-pairs signed-rank test
through GraphPad Prism7.
Immunoprecipitations and immunoblotting
PkRIPR immunoprecipitations (IPs) were performed using transgenic PkRIPR-HA G4 and
wild type PkA1-H.1 parasites. Purified schizonts were dissolved in lysis buffer (1% NP40, 150
mM NaCl, 50 mM Tris pH 8.0, 5 mM EDTA, complete protease inhibitors) and concentrated
culture supernatants were diluted 1:1 in lysis buffer lacking NP40. Supernatants were pre-
cleared using unconjugated agarose beads for 2 h before incubation with anti-HA conjugated
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agarose beads overnight at 4˚C. Two different affinity matrix products were used: HA Tag IP/
Co-IP Kit (Pierce) and anti-HA 3F10-agarose beads (Roche). Beads were washed with 10 mM
Tris-HCl, pH 7.5, 300 mM NaCl, then PBS, and eluted in 100 mM glycine-HCl pH 2.5. Eluates
were neutralized and concentrated using Vivaspin 5kDa MWCO columns, separated on 10%
Bis-Tris NuPAGE gels, and stained with Colloidal Blue. Similarly, immunoprecipitations
using anti-HA 3F10-agarose beads (Roche) and schizont lysates from PkptrampiKO, PkcssiKO
and PkcyrpaiKO were conducted.
Mass spectrometry and analysis
Band slices excised from NuPAGE gels covering the whole separation profile were washed,
reduced and alkylated before digestion with 2 μg/ml trypsin, overnight. Peptides were analyzed
by nano-liquid chromatography tandem mass spectrometry (nano-LC-MS/MS) as described
[56]. Raw data were processed using Maxquant 1.3.0.5 and Perseus 1.4.0.11 and searched
against the P. knowlesi fasta database on PlasmoDB release 25 (immunoprecipitations from
PkRIPR-HA clone G4) and PlasmoDB release 26 (immunoprecipitations from PkptrampiKO,
PkcssiKO and PkcyrpaiKO) and human reference proteome (UNIPROT) using Andromeda.
A decoy database of reversed sequences was used to filter the results, removing false positives,
at a false detection rate of 1%. Label free quantitation was achieved using iBAQ.
Supporting information
S1 Fig. Box-and-whiskers plot of growth inhibition assay (GIA) data of P. vivax field iso-
lates. The isolates were incubated with media control or treated with anti-BSG (MEM M6/6 or
polyclonal antibody) or non-specific mouse or goat IgGs. Whiskers represent min and max
values. Median values of control to anti-BSG antibody treatments are significantly different
(��, p = 0.0078 and p = 0.0021); no significant difference was seen comparing control to non-
immune IgG treatment. Statistical analysis was performed using Wilcoxon matched-pairs
signed-rank test in GraphPad Prism7.
(PDF)
S2 Fig. Alignments of CyRPA sequences from 14 Plasmodium species (A) and RIPR
sequences from 18 Plasmodium species (B). Similar residues (as calculated using MultAlin)
are shown in color. The color corresponds to the residue type (with H,K,R, green; D,E, red; S,
T,N,Q, maroon; C, green; P,G, orange; A,V,L,I,M, pink; F,Y,W, blue). The secondary struc-
tural elements of PfCyRPA are shown above in (A), with beta strands represented as arrows
and helices as coils. The ten predicted EGF domains of RIPR are indicated (B).
(PDF)
S3 Fig. Relative abundance of rh5, cyrpa and ripr mRNA transcripts throughout the life
cycle of P. falciparum, P. knowlesi, and P. vivax. The log2 ratio of mRNA abundance relative
to a pooled reference sample is plotted for 24 time points (P. falciparum), seven time points
(P. knowlesi), or nine time points (P. vivax) (taken from [34]). Colors as follows: cyrpa, blue;
ripr, red; rh5, green.
(PDF)
S4 Fig. Design and genetic validation of inducible knockout parasites PkptrampiKO,
PkcssiKO and PkcyrpaiKO. (A) Schematic of inducible knockout design for ptramp and css
genes in P. knowlesi. ORFs are depicted as dark grey box with predicted signal peptide (SP)
sequence outlined. Also indicated are the homology regions (HR) used in the repair plasmids.
We used guide plasmids pDC45 and pDC982 to target ptramp and guide plasmids pDC89
and pDC1081 to target css. One guide RNA sequence is homologous to a DNA region close
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to the signal peptide sequence of either gene and the other targeted a region close to the stop
codon. Turquoise box represents the introduction of a triple HA tag after the predicted signal
peptide cleavage site. Positions of the loxP sequences are indicated. The loxPint sequence is
derived from the Pkdbpalpha intron 4 sequence. Schematic of floxed ptramp and css loci
before and after excision is shown. (B) PCR screens of wild type (wt = PkpSKIP9-10) and two
clones of PkptrampiKO and of PkcssiKO are shown. Primer positions are indicated in sche-
matic A, with the green primer sequences homologous to the css locus. Primer combinations
are indicated on the top of each image with primer name and sequence listed in S2 Table and
DNA size standards are shown on the left (in kb). (C) Schematic of PkcyrpaiKO design.
Endogenous ORF of cyrpa is shown in grey as two exons connected by one intron. HR
regions used in the repair plasmid are indicated as are the homologous regions of the guide
plasmids pDC591 and pDC1229. In the repair plasmid we replaced the endogenous intron
with the loxPint sequence and inserted a triple HA-tag after the stop codon followed by a
loxP sequence. Schematics of the floxed locus before and after excision are given. (D) PCR
screen of wild type (wt = PkSKIP9-10) and two PkcyrpaiKO clones. Primer positions are
indicated in schematic C and primer combinations for PCR amplification are shown at the
top of each lane. Primer names and sequences are listed in S2 Table. DNA size standards are
shown on the left (in kb).
(PDF)
S5 Fig. Indirect immunofluorescence assay of inducible knockout parasites PkptrampiKO,
PkcssiKO and PkcyrpaiKO. We used anti-HA antibodies (green) to localize HA-PTRAMP,
HA-CSS and CyRPA-HA in the respective transgenic parasite lines (indicated on the left of
each image row) and co-localized this signal with antibodies to the micronemal marker AMA1
(red, top panels) but not with antibodies to the rhoptry bulb marker RhopH2 (red, bottom
panels). Nuclei are stained with DAPI (blue). Scale bar = 2 μm.
(PDF)
S6 Fig. Purification of recombinant proteins corresponding to PkCSS, PkPTRAMP and
two fragments of PkRIPR (Lys287-Glu371 and Asp741-Asp850) used to produce antibod-
ies. After Ni2+-NTA chromatography, proteins purified further by gel filtration (Superdex 75
column for the PkRIPR fragments and Superdex 200 column for PkCSS and PkPTRAMP).
(A) UV traces of gel filtration elution are shown at the top, and Coomassie blue-stained
SDS-PAGE gels of selected fractions at the bottom. Arrows indicate the expected protein
bands: PkRIPR Lys287-Glu371 (~12 kDa), PkRIPR Asp741-Asp850 (~15 kDa), PkCSS (~43
kDa), and PkPTRAMP (~36 kDa). Recombinant PkCSS and PkPTRAMP contain putative N-
linked glycan sites and glycosylation might account for the decreased mobility in SDS-PAGE.
(B) Immunoblots of total PkA1-H.1 lysate separated by SDS-PAGE and probed with either
preimmune or immune rabbit serum. Rabbits were injected with recombinant proteins as
indicated at the bottom of each immunoblot. Molecular mass standards are shown to the left
of each blot. Bands corresponding to expected sizes of the native proteins are indicated by
arrow heads.
(PDF)
S7 Fig. Plasmid map for CRISPR/Cas9 vector pDC2-PK-Cas9-hDHFRyFCU1. P. knowlesi
specific 5’UTR regions of hsp86, ef1alpha and U6 were selected to drive transcription of cas9
nuclease, selection marker hdhfr:yfcu and the protospacer. Total vector size is 12.464 kb (A).
(B) Decorated schematic of 240 bp of vector sequence including U6 terminator, guide RNA
sequence with BbsI cloning sites (arrow heads) for protospacer insertion.
(PDF)
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S8 Fig. Plasmid map of PkpSKIP_pk47. Plasmid is derived from pSKIP vector [41] with
P. knowlesi-specific homology regions to direct the insertion of the DiCre recombinase cassette
into the genome (A). Schematic of loxPint sequence derived from the 83 bp intron-4 sequence
of P. knowlesi dbp alpha with the insertion of a loxP site without affecting RNA branching
points.
(PDF)
S1 Table. Table of P. vivax isolate names, their treatment and their parasitemias
(untreated). The treatment conditions used for each isolate, which are reported in Fig 1E, are
indicated by tick marks.
(PDF)
S2 Table. Primer name and sequences used in this study. Restriction enzyme sites within the
oligonucleotide DNA sequence are listed on the right.
(PDF)
S1 Dataset. Mass spectrometry data tables for anti-HA co-immunoprecipitation experi-
ments using PkRIPR-HA parasites. (A) Table of proteins detected by LC-MS/MS using para-
site lysate and culture supernatant with anti-HA affinity matrix (Roche). Immunoprecipitations
from wild type PkA1-H.1 or PkRIPR-HA parasites were analysed by LC-MS/MS (three techni-
cal replicas) ordered by highest peptide abundance (iBAQ). (B) Table of proteins detected by
LC-MS/MS using parasite lysate and culture supernatant from wild type and PkRIPR-HA para-
sites with Pierce HA-tag IP/Co-IP kit (Thermo Fisher Scientific) ordered by highest peptide
abundance (iBAQ). Analysis was conducted using Maxquant 1.3.0.5 and Perseus 1.4.0.11
searched against the P. knowlesi fasta database (PlasmoDB release v25). IBAQ quantifications
for immunoprecipitations from PkRIPR-HA culture supernatant are highlighted in green, from
PkRIPR-HA schizont lysates in grey and from PkA1-H.1 schizont lysates or culture supernatant
in white. Three top scoring proteins with high peptide abundance in the transgenic parasite line
but minimal or no peptides detected in the wild type parasites are highlighted in yellow. iBAQ
are log10 values.
(XLSX)
S2 Dataset. Mass spectrometry data tables for anti-HA co-immunoprecipitation experi-
ments using PkptrampiKO, PkcssiKO and PkcyrpaiKO parasites. Immunoprecipitations
from purified schizonts of wild type (PkpSKIP 9–10) and PkptrampiKO, PkcssiKO and
PkcyrpaiKO parasites were analysed by LC-MS/MS (three technical replicas) and ordered
by highest peptide abundance (iBAQ). iBAQ are log10 values. Analysis was conducted
using Maxquant 1.3.0.5 and Perseus 1.4.0.11 searched against the P. knowlesi fasta database
(PlasmoDB release v26). Three top scoring proteins with highest peptide abundance in
PkptrampiKO and PkcssiKO parasites are highlighted in yellow; PkCyRPA is highlighted in
orange.
(XLSX)
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